US FDA Quality System Overhaul: Pure Global on Life Beyond ISO 13485

Failed to add items

Sorry, we are unable to add the item because your shopping basket is already at capacity.

Add to cart failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Follow podcast failed

Unfollow podcast failed

US FDA Quality System Overhaul: Pure Global on Life Beyond ISO 13485

Listen for free

View show details

About this listen

In a landmark decision, the US FDA has finalized its rule to replace the decades-old Quality System Regulation with the new Quality Management System Regulation (QMSR). This historic move aligns US medical device standards with the international ISO 13485, marking a significant step towards global harmonization. But this is not a simple copy-and-paste of the global standard. This episode breaks down the critical details of this regulatory shift. We explore why being ISO 13485 certified is not enough to guarantee compliance. We uncover the specific US requirements the FDA has retained, creating a unique hybrid model that manufacturers worldwide must now navigate before the February 2026 deadline. A prime example is a mid-sized American device maker, fully compliant with the old FDA system. They now face a two-year deadline to completely restructure their quality management system, retrain their entire staff, and renegotiate supplier agreements to meet the new risk-centric approach. This is not just new paperwork; it is a fundamental culture shift where one mistake could halt all US sales. Key Takeaways: - The FDA's QMSR is more than just ISO 13485; what key US-specific requirements remain? - If your company is already ISO 13485 certified, are you automatically compliant? - What are the top three priorities for your gap analysis before the 2026 deadline? - How will this change affect your relationships with suppliers and contract manufacturers? - What specific record-keeping practices need to be updated to align with the new rule? - How is the FDA's inspection process expected to change under the new QMSR? - What are the hidden risks of ignoring the subtle differences between the old and new systems? To learn more or for a free consultation, contact us at info@pureglobal.com, visit https://pureglobal.com/, or access our FREE AI tools and medical device database at https://pureglobal.ai/.

No reviews yet